Next Steps For NuVasive Following CEO Resignation

The resignation of CEO Alex Lukianov could signal a shift in the spine firm's approach to sales and profitability that could ultimately make NuVasive as a more attractive acquisition candidate.

NuVasive CEO Alex Lukianov has resigned amid reports that he did not follow the company’s expense reimbursement and personnel policies. Board member and former Life Technologies’ CEO Greg Lucier will take over on an interim basis.

Analysts say the move could signal a shift in its approach to sales and profitability and transform NuVasive into a

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight